SIGNIFICANCE OF PLATELET-ACTIVATING-FACTOR IN MESENTERIC ISCHEMIA-REPERFUSION

被引:14
|
作者
FILEP, J
BRAQUET, P
MOZES, T
机构
[1] SEMMELWEIS UNIV,SCH MED,DEPT PATHOPHYSIOL,H-1445 BUDAPEST,HUNGARY
[2] SEMMELWEIS UNIV,SCH MED,DEPT TRAUMATOL,H-1445 BUDAPEST,HUNGARY
[3] INST HENRI BEAUFOUR,F-92350 LE PLESSIS ROBINS,FRANCE
关键词
D O I
10.1007/BF02536561
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Reperfusion of the ischemic mesenterium is frequently followed by acute circulatory collapse. This review focuses on the possible role of platelet-activating factor (PAF) in ischemia-induced damage. It provides evidence that (i) PAF concentrations are elevated in the mesenteric circulation following temporary ischemia; (ii) administration of exogenous PAF into the superior mesenteric vein mimics many events observed during reperfusion; and (iii) pretreatment of the experimental animals with specific PAF receptor antagonists prevent the circulatory collapse. These findings suggest that PAF may play an important role in the development of circulatory collapse caused by mesenteric ischemia-reperfusion.
引用
收藏
页码:1336 / 1339
页数:4
相关论文
共 50 条
  • [1] PLATELET-ACTIVATING-FACTOR SYNTHESIS AND METABOLISM IN INTESTINAL ISCHEMIA-REPERFUSION INJURY
    MANGINO, MJ
    MURPHY, M
    BOHRER, A
    TURK, J
    MEDIATORS OF INFLAMMATION, 1994, 3 (05) : 393 - 395
  • [2] IMPLICATION OF PLATELET-ACTIVATING-FACTOR (PAF) IN RETINAL DAMAGE INDUCED BY ISCHEMIA-REPERFUSION
    DOLY, M
    DROYLEFAIX, MT
    MILLERIN, M
    BRAQUET, P
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1991, 32 (04) : 1031 - 1031
  • [3] PLATELET-ACTIVATING-FACTOR INTERACTION WITH TUMOR-NECROSIS-FACTOR IN MYOCARDIAL ISCHEMIA-REPERFUSION INJURY
    SQUADRITO, F
    IOCULANO, M
    ALTAVILLA, D
    ZINGARELLI, B
    CANALE, P
    CAMPO, GM
    SAITTA, A
    CALAPAI, G
    BUSSOLINO, F
    CAPUTI, AP
    JOURNAL OF LIPID MEDIATORS, 1993, 8 (01): : 53 - 65
  • [4] ROLE OF PLATELET-ACTIVATING-FACTOR IN ISCHEMIA-REPERFUSION INJURY OF ISOLATED RABBIT HEARTS - PROTECTIVE EFFECT OF A SPECIFIC PLATELET-ACTIVATING-FACTOR ANTAGONIST, TCV-309
    KATOH, S
    TOYAMA, J
    KODAMA, I
    KOIKE, A
    ABE, T
    CARDIOVASCULAR RESEARCH, 1993, 27 (08) : 1430 - 1434
  • [5] PLATELET-ACTIVATING-FACTOR AND ISCHEMIA
    POTRON, G
    PETITFRERE, E
    NGUYEN, P
    CLINICAL HEMORHEOLOGY, 1993, 13 (02): : 155 - 176
  • [6] PLATELET-ACTIVATING-FACTOR ANTAGONIST WEB2086 ATTENUATES ISCHEMIA-REPERFUSION LUNG EDEMA
    CHEN, C
    HSIUE, T
    CHANG, H
    AMERICAN REVIEW OF RESPIRATORY DISEASE, 1993, 147 (04): : A365 - A365
  • [7] BENEFICIAL EFFECT OF PLATELET-ACTIVATING-FACTOR ANTAGONIST TCV-309 ON RENAL ISCHEMIA-REPERFUSION INJURY
    YIN, M
    KURVERS, HAJM
    BUURMAN, WA
    TANGELDER, GJ
    BOOSTER, MH
    DAEMEN, JHC
    KONDRACKI, S
    KOOTSTRA, G
    TRANSPLANTATION PROCEEDINGS, 1995, 27 (01) : 774 - 776
  • [8] INFLAMMATION AND PLATELET-ACTIVATING-FACTOR PRODUCTION DURING HEPATIC ISCHEMIA REPERFUSION
    ZHOU, WG
    MCCOLLUM, MO
    LEVINE, BA
    OLSON, MS
    HEPATOLOGY, 1992, 16 (05) : 1236 - 1240
  • [9] EFFECT OF PENTOXIFYLLINE ON TISSUE-INJURY AND PLATELET-ACTIVATING-FACTOR PRODUCTION DURING ISCHEMIA-REPERFUSION INJURY
    ADAMS, JG
    DHAR, A
    SHUKLA, SD
    SILVER, D
    JOURNAL OF VASCULAR SURGERY, 1995, 21 (05) : 742 - 749
  • [10] PLATELET-ACTIVATING-FACTOR ANTAGONIST TCV-309 PROTECTS RAT KIDNEYS AGAINST ISCHEMIA-REPERFUSION INJURY
    YIN, M
    KURVERS, HAJM
    BUURMAN, WA
    TANGELDER, GJ
    TIEBOSCH, ATM
    DAEMEN, JHC
    KOOTSTRA, G
    TRANSPLANTATION PROCEEDINGS, 1995, 27 (05) : 2844 - 2846